Guangwen W. Yuan
Chinese Academy Of Medical Science And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Glucose restriction reprograms lipid metabolism and enhances immunotherapy through ZNRF3-Wnt-SCD signaling axis.
Journal: Journal for immunotherapy of cancer
Published: May 16, 2026
Safety and efficacy of secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer after first-line PARPi maintenance therapy
Journal: Zhonghua fu chan ke za zhi
Published: August 25, 2025
Suvemcitug plus chemotherapy in women with platinum-resistant recurrent ovarian cancer: the SCORES randomized, double-blinded, phase 3 trial.
Journal: Nature cancer
Published: April 09, 2025
Corrigendum to 'Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer: a multicenter, open-label, non-inferiority, randomized controlled trial' [Journal of the National Cancer Center 4 (2024) 135-141].
Journal: Journal of the National Cancer Center
Published: March 05, 2025
The impact of peritoneal cytology test results on the prognosis of patients with uterine serous carcinoma
Journal: Zhonghua yi xue za zhi
Published: February 19, 2025
AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cancer.
Journal: Gynecologic oncology
Published: January 23, 2025
Secondary Cytoreductive Surgery for Ovarian Cancer With Second Platinum-Sensitive Recurrence: A Multicentre Retrospective Cohort Study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: November 28, 2024
Survival prediction in peritoneal mesothelioma: a nomogram based on SEER data and a Chinese cohort.
Journal: Frontiers in endocrinology
Published: May 14, 2024
TTN Mutation in Endometrial Endometrioid Carcinoma Is Associated with Poor Clinical Outcomes and High Tumor Mutation Burden.
Journal: Cancer investigation
Published: April 26, 2024
Outcomes of secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer progressed after prior poly (adenosine diphosphate-ribose) polymerase inhibitors: A retrospective cohort study.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: March 04, 2024
Suvemcitug plus chemotherapy for platinum-resistant epithelial ovarian, fallopian tube and primary peritoneal cancer: A phase 1b dose-escalation trial.
Journal: Gynecologic oncology
Published: January 04, 2024
Last Updated: 09/26/2026